Drug policy of Portugal

Last updated

The drug policy of Portugal, informally called the "drug strategy", was put in place in 2000, and came into effect in July 2001. Its purpose was to reduce the number of new HIV/AIDS cases in the country, as it was estimated around half of new cases came from injection drug use.

Contents

The policy consisted of multiple methods to reduce the spread of HIV, among which were harm reduction efforts, information to the public and in particular to populations most at risk about how HIV is spread, establishing treatment facilities and easier access to substitution treatment for drug addicts, establishing so-called dissuasion commissions to persuade drug addicts to go into treatment, and all drug treatment and control units were reorganized into one comprehensive unit. In addition, the existing practice of giving drug addicts a waiver for drug possession was codified in a new law. The law (Drug Law 30/2000) maintained the status of illegality for using or possessing any drug for personal use without authorization. However, for persons addicted to said drug, their case was now deemed an administrative offence. [1] The authority to impose penalties or sanctions in these cases was transferred from the police and justice system to so-called dissuasion commissions if the amount possessed was no more than a ten-day supply of that substance. [2] [1]

Drug use in Portugal prior to 1999

Portugal's first major drug laws were enacted in 1924 [3] and 1926, [4] mainly incorporating into domestic law the International Opium Convention. [5] In 1970, the country's drug law underwent a major update, with the introduction of a legal definition of narcotic products, a drug schedule, and legal regime for punishing drug trafficking and consumption. [5] [6] Drug use and abuse expanded in the early and mid-1970s, gradually becoming a major societal problem. [5] The 1963 Mental Health Act made reference to the need of facilities for treating drug abuse, but there was no nationwide coverage nor a coordinating structure to achieve so. [5] Following the ratification of the Single Convention on Narcotic Drugs (in December 1971) and of the Convention on Psychotropic Substances (in April 1979), Portuguese drug law underwent a new major update in 1983, harshening the fight against drug trafficking and criminal organisations, and softnening the penalties for drug consumption, in order to incentivise users to voluntarily seek medical treatment. [7] [8] Concurrently, in the 1970s and 1980s, the Portuguese government created a series of organizations to study and reduce drug use, including the Drug Fighting Coordination Office (GCCD), the Drug Prophylaxis Studies Center (CEPD), and the Drug Control and Research Center (CICD). [5] In the 1990s, heroin use skyrocketed, resulting in high levels of drug addiction and the spread of the AIDS epidemic. Estimates for the late 1990s determined there were between fifty and sixty thousand drug addicts out of a population of 10 million. [9] This resulted in a public health crisis in Portugal, paving the way for a paradigm-shifting approach to approach drug use as a health crisis instead of a criminal one. [10]

Status in 1999

In 1999, Portugal had the highest rate of HIV amongst injecting drug users in the European Union. There were 2,000 new cases a year, in a country of 10 million people. In 1997, 45% of HIV reported AIDS cases recorded originated among IV drug users, [11] so targeting drug use was seen as an effective avenue of HIV prevention. The number of heroin users was estimated to be between 50,000 and 100,000 at the end of the 1990s. [12] This led to the adoption of The National Strategy for the Fight Against Drugs (NSFAD) in 1999. A vast expansion of harm reduction efforts, doubling the investment of public funds in drug treatment and drug prevention services, and changing the legal framework dealing with minor drug offences were the main elements of the policy thrust.

According to Dr João Castel-Branco Goulão, one of the architects of the decriminalisation policy, a reason why the programme was able to get off the ground was because in Portugal, the problem could not be blamed on any ethnic or economic group in society (as in Brazil and the favelas), allowing other prejudices to be put aside. The policy was, however, initially opposed by right-wing politicians, who feared it would turn Portugal into a narco-state. [13]

Harm reduction

The needle exchange programme, "Say NO! to a used syringe", is a nationwide syringe exchange program which has been ongoing since October 1993, involving some 2,500 pharmacies throughout Portugal. It is run by the National Commission for the Fight against AIDS - set up by the Ministry of Health and the National Association of Pharmacies - a non-governmental organisation representing the majority of Portuguese pharmacies. All drug users can exchange used syringes at pharmacy counters across the country. They get a kit with clean needle syringes, a condom, rubbing alcohol and a written message motivating for AIDS prevention and addiction treatment. From 1994 to 1999, pharmacies delivered around three million syringes annually. [14]

Several low threshold projects were initiated after 1999, particularly in the period 2003-2005, where outreach teams have promoted safe injection practices and supplied needles and injecting equipment on the street. Many of these projects are still running.

At programme start, a media campaign was launched by television, radio and the press, and posters were put up in discothèques and bars in order to attract the attention of the target population to the problems associated with drug addiction, in particular HIV transmission through needle-sharing. [15]

Project objectives have been threefold: To reduce frequency of sharing needles and syringes, to change other IDU (Intravenous Drug User) behaviors that create negative attitudes among the population in general, and to change attitudes towards IDUs in the general population to facilitate addiction prevention and treatment. [16]

Expanding drug treatment

In 1987, the Centro das Taipas in Lisbon was created, an institution specialising in the treatment of drug addicts. This centre consisted of a consultation service, a day centre and a patient detoxification unit. This facility was the responsibility of the Ministry of Health, and was the first in the network of centres specialising in treating drug addiction which now covers the whole country.

Healthcare for drug users in Portugal is organised mainly through the public network services of treatment for illicit substance dependence, under the Institute on Drugs and Drug Addiction, and the Ministry of Health. In addition to public services, certification and protocols between NGOs and other public or private treatment services ensure a wide access to quality-controlled services encompassing several treatment modalities. The public services provided are free of charge and accessible to all drug users who seek treatment.

There are 73 specialised treatment facilities (public and certified private therapeutic communities), 14 detoxification units, 70 public outpatient facilities and 13 accredited day centres. Portugal is divided into 18 districts. There is full coverage of drug outpatient treatment across all but four districts (districts not covered are located in the north of the country: Viana do Castelo, Bragança, Viseu and Guarda).

Substitution treatment

Substitution treatment is today widely available in Portugal, through public services such as specialized treatment centers, health centers, hospitals and pharmacies as well as NGOs and non-profit organizations.

The Portuguese substitution program started in 1977 in Oporto. The CEPD/North (Study Centre on Drug Prevention/North), using methadone as the substituting substance, was the only unit using opioid substitution until 1992. However, the increase in numbers of drug addicts (including an "explosion" at the beginning of the 1990s), together with the growth of AIDS and hepatitis C among this population, led to a change in attitude. After 1992, methadone-substitution programs were extended to several CATs (Centres of Assistance to drug addicts). Overall, the programmes were medium or high threshold. With the exception of occasional activities in a slum area in Lisbon, there were no true low-threshold programs (risk- and harm reduction) prior to 2001.

From 2000 to 2008, the number of people in Portugal receiving substitution treatment increased from 6040 to 25 808 (24 312 in 2007), 75% of whom were in methadone maintenance treatment. The remaining patients received high dosage buprenorphine treatment.

Buprenorphine had been available since 1999, and later also the buprenorphine/naloxone combination.

Decree-Law 183/2001 Article 44.1 and Decree-Law 15/93 Article 15.1-3 stipulate that methadone treatment can be initiated by treatment centers whereas buprenorphine treatment can be initiated by any medical doctor, specialized medical doctors and treatment centers. From 2004, there was also the provision of buprenorphine in pharmacies.

After-care and social re-integration

After-care and social re-integration of drug users in Portugal is organised through three major programmes targeting different regions in Portugal (Programa Vida Emprego, Programa Quadro Reinserir and the PIDDAC incentives for re-integration). All three programmes finance different initiatives and projects supporting drug users through training opportunities, employment support, and/or housing.

Monitoring drug treatment

A national treatment monitoring system is being developed but has not yet been implemented in all regions. National routine statistics from outpatient centres on substitution clients are available (for clients in methadone and buprenorphine programmes). [15]

Laws and regulations

In July 2001, a new law maintained the status of illegality for using or possessing any drug for personal use without authorization. The offense was changed from a criminal one, with prison as a possible punishment, to an administrative one if the amount possessed was no more than a ten-day supply of that substance. [2] This was in line with the de facto Portuguese drug policy before the reform. Drug addicts were then to be aggressively targeted with therapy or community service rather than fines or waivers. [17] Even if there are no criminal penalties, these changes did not legalize drug use in Portugal. Possession has remained prohibited by Portuguese law, and criminal penalties are still applied to drug growers, dealers and traffickers. [18] [19] Despite this, the law was still associated with a nearly 50% decrease in convictions and imprisonments of drug traffickers from 2001 to 2015. [20]

Regulation

Individuals found in possession of small quantities of drugs are issued summons. The drugs are confiscated, and the suspect is interviewed by a "Commission for the Dissuasion of Drug Addiction" (Comissões para a Dissuasão da Toxicodependência – CDT). These commissions are made up of three people: A social worker, a psychiatrist, and an attorney. [19] [21] The dissuasion commission have powers comparable to an arbitration committee, but restricted to cases involving drug use or possession of small amounts of drugs. There is one CDT in each of Portugal's 18 districts.

The committees have a broad range of sanctions available to them when ruling on the drug use offence. These include:

If the person is addicted to drugs, they may be admitted to a drug rehabilitation facility or be given community service, if the dissuasion committee finds that this better serves the purpose of keeping the offender out of trouble. The committee cannot mandate compulsory treatment, although its orientation is to induce addicts to enter and remain in treatment. The committee has the explicit power to suspend sanctions conditional upon voluntary entry into treatment. If the offender is not addicted to drugs, or unwilling to submit to treatment or community service, he or she may be given a fine. [2] [22] [23] [24]

For example, in 2005, there were 3,192 commission hearings on drug use. 83% of commissions were suspended because the offender had no prior convictions or because the offender agreed to seek drug addiction treatment. 15% ended with some form of a sanction, which could have included a verbal warning, a fine, a loss of professional licenses, among other administrative actions. The remaining 2.5% were found not guilty or responsible. Arrest rates dropped to zero, because there were no longer any criminal penalties attached to possession. [25]

Law enforcement

Every year, Portuguese law enforcement bodies confiscate several tonnes of cocaine, with a record amount of more than 34.5 tonnes seized in 2006. A regular increase in quantities of cannabis resin seized could also be observed over recent years, though there has been a recent decline between 2008 (61 tonnes) and 2009 (23 tonnes). [2]

Observations

There is little reliable information about drug use, injecting behaviour or addiction treatment in Portugal before 2001, when general population surveys commenced. Until then, there were the indicators on lifetime prevalence amongst youth, collected as part of the European School Survey Project on Alcohol and Other Drugs (ESPAD), and some other (less reliable) data available through the EMCDDA. [24]

Thorough studies on how the various efforts have been implemented were not conducted. Thus, a causal effect between strategy efforts and these developments cannot be firmly established. [18] There are, however, statistical indicators that suggest the following correlations between the drug strategy and the following developments, starting with the establishment of the NSAFD in 1999:

Table and chart comparing countries

One is for rates and one is for counts.

Drug overdose death rates for European countries. Drug overdose death rates for European countries.png
Drug overdose death rates for European countries.

Consumption and possession

In Portugal, recreational use of cannabis is forbidden by law. In July 2018, legislation was signed into law to allow for the medical use of cannabis in Portugal and its dispensation at pharmacies. Portugal signed all the UN conventions on narcotics and psychotropic to date. With the 2001 decriminalization bill, the consumer is now regarded as a patient and not as a criminal (having the amount usually used for ten days of personal use is not a punishable crime). According to the libertarian think tank Cato Institute, illegal drug use among Portuguese teenagers declined after 2001, and 45 percent of the country's heroin addicts sought medical treatment.

Cultivation and distribution

Cannabis Store Amsterdam in Odivelas, Lisbon Metropolitan Area: Cannabis cultivation by ordinary people is illegal in Portugal even when performed for small-scale self-consumption at home. By the early 2020s, cannabis shops became popular in the country but were only allowed to sell cannabis products without THC. Lisbon 2021 IMG 20210923 064604364 (51528307529).jpg
Cannabis Store Amsterdam in Odivelas, Lisbon Metropolitan Area: Cannabis cultivation by ordinary people is illegal in Portugal even when performed for small-scale self-consumption at home. By the early 2020s, cannabis shops became popular in the country but were only allowed to sell cannabis products without THC.

The cultivation of cannabis, even on a very small-scale home grown basis for personal use only, can legally be prosecuted. However, an unknown number of enthusiasts of small-scale home-cultivation grow the plants with a high degree of secrecy due to the legal punishment they could face if prosecuted, and due to potential social stigma as well. In neighboring Spain, small-scale cultivation of cannabis plants for personal use only, is tolerated by the authorities and there are many grow shops across the country selling their products physically and online. In 2003 another update to the "Portuguese drugs law" brought the criminalization of the possession of cannabis seeds, except certified industrial hemp seed. This law made the buying of cannabis seeds from legal and financially transparent online cannabis seed shops based in other European Union member states, such as neighboring Spain or the Netherlands, an unlawful transaction when performed by Portuguese residents. The provision of seeds and tools to produce and consume cannabis is also illegal in the country. Production and distribution of hemp products is legal but regulated. There are a small number of hemp shops in Portugal and hemp products are legal.

See also

Related Research Articles

<span class="mw-page-title-main">Heroin</span> Opioid used as an analgesic and a recreational drug for its euphoric effects

Heroin, also known as diacetylmorphine and diamorphine among other names, is a morphinan opioid substance synthesized from the dried latex of the Papaver somniferum plant; it is mainly used as a recreational drug for its euphoric effects. Medical-grade diamorphine is used as a pure hydrochloride salt. Various white and brown powders sold illegally around the world as heroin are routinely diluted with cutting agents. Black tar heroin is a variable admixture of morphine derivatives—predominantly 6-MAM (6-monoacetylmorphine), which is the result of crude acetylation during clandestine production of street heroin. Heroin is used medically in several countries to relieve pain, such as during childbirth or a heart attack, as well as in opioid replacement therapy.

<span class="mw-page-title-main">Drug policy of the Netherlands</span>

While recreational use, possession and trade of non-medicinal drugs described by the Opium Law are all technically illegal under Dutch law, official policy since the late 20th century has been to openly tolerate all recreational use while tolerating the other two under certain circumstances. This pragmatic approach was motivated by the idea that a drug-free Dutch society is unrealistic and unattainable, and efforts would be better spent trying to minimize harm caused by recreational drug use. As a result of this gedoogbeleid, the Netherlands is typically seen as much more tolerant of drugs than most other countries.

<span class="mw-page-title-main">Harm reduction</span> Public health policies which lessen negative aspects of problematic activities

Harm reduction, or harm minimization, refers to a range of intentional practices and public health policies designed to lessen the negative social and/or physical consequences associated with various human behaviors, both legal and illegal. Harm reduction is used to decrease negative consequences of recreational drug use and sexual activity without requiring abstinence, recognizing that those unable or unwilling to stop can still make positive change to protect themselves and others.

<span class="mw-page-title-main">Needle and syringe programmes</span> Method of providing drug users with uninfected equipment

A needle and syringe programme (NSP), also known as needle exchange program (NEP), is a social service that allows injecting drug users (IDUs) to obtain clean and unused hypodermic needles and associated paraphernalia at little or no cost. It is based on the philosophy of harm reduction that attempts to reduce the risk factors for blood-borne diseases such as HIV/AIDS and hepatitis.

<span class="mw-page-title-main">Opioid use disorder</span> Medical condition

Opioid use disorder (OUD) is a substance use disorder characterized by cravings for opioids, continued use despite physical and/or psychological deterioration, increased tolerance with use, and withdrawal symptoms after discontinuing opioids. Opioid withdrawal symptoms include nausea, muscle aches, diarrhea, trouble sleeping, agitation, and a low mood. Addiction and dependence are important components of opioid use disorder.

Students for Sensible Drug Policy (SSDP) is an international nonprofit organization advocacy and education organization with focus on drug policy, war on drugs, marijuana legalization, psychedelics, juvenile justice and youth rights, drug decriminalization, criminal justice reform. SSDP promotes global youth civic engagement as a tool in reforming drug policy.

<span class="mw-page-title-main">National Institute on Drug Abuse</span> Branch of the National Institutes of Health in the United States

The National Institute on Drug Abuse (NIDA) is a United States federal government research institute whose mission is to "advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health."

A methadone clinic is a medical facility where medications for opioid use disorder (MOUD) are dispensed-—historically and most commonly methadone, although buprenorphine is also increasingly prescribed. Medically assisted drug therapy treatment is indicated in patients who are opioid-dependent or have a history of opioid dependence. Methadone is a schedule II (USA) opioid analgesic, that is also prescribed for pain management. It is a long-acting opioid that can delay the opioid withdrawal symptoms that patients experience from taking short-acting opioids, like heroin, and allow time for withdrawal management. In the United States, by law, patients must receive methadone under the supervision of a physician, and dispensed through an Opioid Treatment Program (OTP) certified by the Substance Abuse and Mental Health Services Administration and registered with the Drug Enforcement Administration.

A drug policy is the policy regarding the control and regulation of psychoactive substances, particularly those that are addictive or cause physical and mental dependence. While drug policies are generally implemented by governments, entities at all levels may have specific policies related to drugs.

<span class="mw-page-title-main">Drug liberalization</span> Process of reducing drug prohibition laws

Drug liberalization is a drug policy process of decriminalizing or legalizing the use or sale of prohibited drugs. Variations of drug liberalization include: drug legalization, drug re-legalization and drug decriminalization. Proponents of drug liberalization may favor a regulatory regime for the production, marketing, and distribution of some or all currently illegal drugs in a manner analogous to that for alcohol, caffeine and tobacco.

Illicit drug use in Australia is the recreational use of prohibited drugs in Australia. Illicit drugs include illegal drugs, pharmaceutical drugs when used for non-medical purposes, and other substances used inappropriately. According to government and community organisations, the use and abuse, and the illegality, of illicit drugs is a social, health and legal issue that creates an annual illegal market estimated to be worth A$6.7 billion. Estimates made in 2022 place the figure at A$11.3 billion per year.

The drug policy of Sweden is based on zero tolerance focusing on prevention, treatment, and control, aiming to reduce both the supply of and demand for illegal drugs. The general drug policy is supported by all major Swedish political parties with the exceptions of the Left Party - which advocates for the decriminalization of private consumption - and 5 of the 7 major parties' youth wings.

The U.S. state of Oregon has various policies restricting the production, sale, and use of different substances. In 2006, Oregon's per capita drug use exceeded the national average. The most used substances were marijuana, methamphetamine and illicit painkillers and stimulants.

Heroin-assisted treatment (HAT), or diamorphine-assisted treatment, refers to a type of Medication-Assisted Treatment (MAT) where semi-synthetic heroin is prescribed to opiate addicts who do not benefit from, or cannot tolerate, treatment with one of the established drugs used in opiate replacement therapy such as methadone or buprenorphine. For this group of patients, heroin-assisted treatment has proven superior in improving their social and health situation. Heroin-assisted treatment is fully a part of the national health system in Switzerland, Germany, the Netherlands, Canada, and Denmark. Additional trials are being carried out in the United Kingdom, Norway, and Belgium.

This is a history of drug prohibition in the United States.

Drugs considered addictive or dangerous in the United Kingdom are called "controlled substances" and regulated by law. Until 1964 the medical treatment of dependent drug users was separated from the punishment of unregulated use and supply. Under this policy drug use remained low; there was relatively little recreational use and few dependent users, who were prescribed drugs by their doctors as part of their treatment. From 1964 drug use was decreasingly criminalised, with the framework still in place as of 2014 largely determined by the Misuse of Drugs Act.

Low-threshold treatment programs are harm reduction-based health care centers targeted towards people who use substances. "Low-threshold" programs are programs that make minimal demands on the patient, offering services without attempting to control their intake of drugs, and providing counselling only if requested. Low-threshold programs may be contrasted with "high-threshold" programs, which require the user to accept a certain level of control and which demand that the patient accept counselling and cease all drug use as a precondition of support.

Martin T. Schechter is a Canadian epidemiologist recognized for contributions to research about HIV prevention and treatments, addiction research, and Indigenous health research. He is a professor and was the founding director of the School of Population and Public Health in the Faculty of Medicine at the University of British Columbia (UBC). Schechter received his Order of British Columbia in 1994 alongside BC's first Nobel Prize laureate Michael Smith and noted Indigenous artist Bill Reid. In 2022, Schechter was named as a Member of the Order of Canada.

Discrimination against drug addicts is a form of discrimination against people who suffer from a drug addiction.

Opioid agonist therapy (OAT) is a treatment in which prescribed opioid agonists are given to patients who live with Opioid use disorder (OUD). In the case of methadone maintenance treatment (MMT), methadone is used to treat dependence on heroin or other opioids, and is administered on an ongoing basis.

References

  1. 1 2 "Archived copy" (PDF). Archived from the original (PDF) on 6 February 2020. Retrieved 6 February 2020.{{cite web}}: CS1 maint: archived copy as title (link)
  2. 1 2 3 4 5 "EMCDDA:Drug policy profiles, Portugal, June 2011". Emcdda.europa.eu. 17 August 2011. Retrieved 27 July 2014.
  3. Law No. 1687 of December 9, 1924 (in Portuguese). Congress of the Republic. Retrieved 28 January 2024.
  4. Decree Law No. 12,210 of August 27, 1926 (in Portuguese). Government of Portugal. Retrieved 28 January 2024.
  5. 1 2 3 4 5 "Histórico de 1924 a 1977" [History > 1924 to 1977]. General Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD) (in Portuguese). Retrieved 28 January 2024.
  6. Decree Law No. 420/70 of September 3, 1970 (in Portuguese). Government of Portugal. Retrieved 28 January 2024.
  7. "Histórico de 1982 a 1989" [History > 1982 to 1989]. General Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD) (in Portuguese). Retrieved 28 January 2024.
  8. Decree Law No. 430/83 of December 13, 1983 (in Portuguese). Government of Portugal. Retrieved 28 January 2024.
  9. Russoniello, K (2012). "The devil (and drugs) in the details: Portugal's focus on public health as a model for decriminalization of drugs in Mexico". Yale Journal of Health Policy, Law, and Ethics. 12 (2): 371–431. PMID   23175919.
  10. Hughes, Caitlin Elizabeth; Stevens, Alex (January 2012). "A resounding success or a disastrous failure: Re-examining the interpretation of evidence on the Portuguese decriminalisation of illicit drugs: A resounding success or a disastrous failure" (PDF). Drug and Alcohol Review. 31 (1): 103. doi:10.1111/j.1465-3362.2011.00383.x. PMID   22212070.
  11. CNLCS, 1998
  12. EMCDDA, 2,000
  13. Vorobyov, Niko (2019) Dopeworld. Hodder, UK. p. 347-349
  14. EMCDDA, 2000. Reviewing current practice in drug-substitution treatment in the European Union Archived 2 April 2022 at the Wayback Machine
  15. 1 2 EMCDDA
  16. Ferreira MO, Madeira A, Teles A, Matias L, Amaro F; International Conference on AIDS. Int Conf AIDS. 1996 Jul 7-12; 11: 152 (abstract no. We.C.3545).
  17. "Portugal legalizes drug use". BBC News. 7 July 2000. Retrieved 21 August 2009.
  18. 1 2 3 4 Hughes, Caitlin; Stevens, Alex (December 2007), The Effects of Decriminalization of Drug Use in Portugal (PDF), Briefing Paper 14, Oxford: Beckley Foundation, archived from the original (PDF) on 26 April 2015
  19. 1 2 United Nations Office on Drugs and Crime (2009). Confronting unintended consequences: Drug control and the criminal black market (PDF). United Nations. p.  174. ISBN   978-92-1-148240-9.{{cite book}}: |journal= ignored (help)
  20. Laqueur, Hannah (June 2015). "Uses and Abuses of Drug Decriminalization in Portugal". Law & Social Inquiry. 40 (3): 746–781. CiteSeerX   10.1.1.957.7277 . doi:10.1111/lsi.12104. S2CID   9431572.
  21. Hammond, Claudia (18 June 2009). "Lisbon's light-touch drugs policy". BBC News. Retrieved 24 August 2009.
  22. Gillespie, Nick (22 June 2009). "Drug Decriminalization in Portugal". Reason. 2009 (July). Archived from the original on 15 August 2009. Retrieved 24 August 2009.
  23. Easton, Mark (1 July 2009). "How Portugal treats drug addicts". BBC News. Retrieved 24 August 2009.
  24. 1 2 Loo, Mirjam van het; Van Beusekom, Ineke; Kahan, James P. (2002). "Decriminalization of Drug Use in Portugal: The Development of a Policy". The Annals of the American Academy of Political and Social Science. 582: 49–63. doi:10.1177/000271620258200104. JSTOR   1049733. S2CID   145433349.
  25. Anderson, Steve (16 October 2017). "European Drug Policy: The Cases of Portugal, Germany, and The Netherlands". The Eastern Illinois University Political Science Review. 1 (1).
  26. 1 2 3 Cardoso, Manuel; Santos, Ana Sofia; Duarte, Óscar (2009). "New Development, Trends and in-depth information on selected issues" (PDF). Portuguese Focal Point report (2008 data) to the EMCDDA. Lisbon, Portugal: Institute for Drug and Drug Addiction (IDT, I.P.). Archived from the original (PDF) on 25 July 2011. Retrieved 11 June 2011.
  27. 1 2 Greenwald, Glenn (2 April 2009). "Drug Decriminalization in Portugal: Lessons for Creating Fair and Successful Drug Policies" (PDF). Cato Institute. Retrieved 14 February 2015.
  28. Cato Institute Annual Report 2009
  29. Vastag, Brian (7 April 2009). "5 Years After: Portugal's Drug Decriminalization Policy Shows Positive Results". Scientific American . Retrieved 14 February 2015.
  30. Szalavitz, Maia (26 April 2009). "Drugs in Portugal: Did Decriminalization Work?". Time . Retrieved 14 February 2015.
  31. 1 2 Vale de Andrade & Carapinha, paula & Ludmila (2010). "Drug decriminalisation in Portugal". BMJ. 341: c4554. doi:10.1136/bmj.c4554. PMID   20833743. S2CID   30409038.
  32. 1 2 3 4 5 Hughes, Caitlin; Stevens, Alex (21 July 2010). "What can we learn from the Portuguese decriminalization of illicit drugs?" (PDF). British Journal of Criminology. Oxford University Press 10.1093/bjc/azq038. 50 (6): 1014. doi:10.1093/bjc/azq038. Archived from the original (PDF) on 21 August 2014.
  33. The Effect of Drug Decriminalization in Portugal on Homicide and Drug Mortality Rates
  34. "crimprev. Crimprev info n°7bis – Drug use and possession: the criminalisation-decriminalisation equation". Lodel.irevues.inist.fr. Archived from the original on 27 July 2014. Retrieved 27 July 2014.
  35. "crimprev. Crimprev info n°29bis – (De)criminalisation of the use and possession of drugs (Deutschland, Italy, Spain)*". Lodel.irevues.inist.fr. Archived from the original on 27 July 2014. Retrieved 27 July 2014.
  36. Szalavitz, Maia (23 November 2010). "Portugal's Drug Experience: New Study Confirms Decriminalization Was a Success". Time . Retrieved 25 March 2016.
  37. Gonçalves, Ricardo; Lourenço, Ana; Silva, Sofia Nogueira da (February 2015). "A social cost perspective in the wake of the Portuguese strategy for the fight against drugs". International Journal of Drug Policy. 26 (2): 199–209. doi:10.1016/j.drugpo.2014.08.017. hdl: 10400.14/20319 . PMID   25265899.
  38. Lowther, Ed; Brocklehurst, Steven. (15 December 2020). Scotland's drug death crisis in six charts. BBC News. Data sources listed are EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) and National Records of Scotland.
  39. 1 2 Statistical Bulletin 2023 — drug-induced deaths. See table of yearly drug deaths by country there. From European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).